Sophie de Carné

L’Université Paris-Saclay et sa communauté universitaire (Facultés, IUT, Écoles, Universités membres associés) ont décidé de mettre fin à leur activité sur le réseau X (anciennement Twitter). Retrouvez-nous sur BlueSky : univparissaclay.bsky.social

Thank you to everyone who made Twitter a meaningful place for scientific exchange. I hope to continue these conversations on the other platform as the mass exodus continues 😉

As I settle into this new chapter, I’ve decided to leave X/Twitter to explore more positive platforms. You can find me on BlueSky 🦋 @sdecarne.bsky.social and on LinkedIn.

I’m thrilled to share that I’ve started a new position as Junior Group Leader at @GustaveRoussy, leading the Inflammation and Cancer Plasticity Lab. My lab will study the effects of systemic factors associated with metabolic diseases on cancer initiation and progression.

@drmcaswell @CRUKCOLcentre Amazing! Congrats, Debbie.

Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others. Details & registration: eacr.org/conference/boe…

@Roedejam @Nature Studies show that ‘merit-based’ selection is skewed by unconscious bias. Major US Philharmonics had only men until they introduced blind auditions in the 1970s. Once the process became anonymous, women were recruited at equal rates within a decade.

@Nature The prize should be based upon merit, not demographics. Give me a break, @Nature

Not for the first time, all Nobel Prizes in scientific disciplines this year have been awarded to men

Study of new personalised cancer therapies could ‘transform’ how the disease is treated theguardian.com/science/2024/o…

How can we extend responses to KRASG12C drugs? Out now in @NatureComms, combining Revolution Medicines’ RAS(ON) G12C-selective inhibitor with a SHP2 inhibitor and immune checkpoint blockade to study their effects on KRAS-mutant lung tumours of varying immunogenicities.

@giampazolias @MCRCnews @CRUK_MI @ERC_Research Amazing news! Congrats Evangelos.

I feel extremely honoured to have been awarded an ERC starting grant #ERCStG to pursue our work on nutrient-host-microbiome interactions in cancer immunity @CRUK_MI. Thank you @ERC_Research for this incredible opportunity. Postdoc positions to be announced soon💥 #WatchThisSpace

✨ Elles sont médecins, chercheuses, scientifiques à Gustave Roussy ✨ Dr Elsa Bernard est cheffe de groupe de l'équipe oncologie clinique computationnelle à @GustaveRoussy. Découvrir son portrait ⤵

Beyond excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells now published @Dev_Cell ! 🧵 [1/15] cell.com/developmental-…

The data are clear: taking sex and gender into account in research and using that knowledge to change health care could benefit billions of people go.nature.com/3K6LAe0

Excited to share our review on “Analyzing the functional effects of DNA variants with gene editing” @CellRepMethods sciencedirect.com/science/articl… With recent advancements in saturation genome editing, base editing and prime editing, this is a rapidly progressing and exciting field!

@giampazolias @ScienceMagazine @ReiseSousaLab @TheCrick Congrats Evangelos and team. Amazing story!

Very excited to share our latest work, out today in @ScienceMagazine, on the serendipitous finding that vitamin D ☀️ regulates the gut microbiome to promote cancer immunity🦠 science.org/doi/10.1126/sc… 🧵👇 @ReiseSousaLab @TheCrick

Check out our latest paper science.org/doi/10.1126/sc…. Congratulations to @giampazolias who led the work. Thanks to very many who helped. Great collaboration with Tine Jess and @RominaGoldszmid labs. Tweetorial will follow soon.

Our paper is out! Excited to be part of such an amazing team unravelling the complexities of lung tumour/TME coevolution in #TRACERx Big thanks to all those involved in the project and who supported our work. Presented by @CharlesSwanton at #AACR24 Check out our Tweetorial below.

@EnfieldKatey @CharlesSwanton Congrats Katey and team!